Trial Profile
Effects of Two Different Doses of Rec 0/0438 Administered by Intravesical Instillation in Patients With Neurogenic Detrusor Overactivity Due to Spinal Cord Injury: a Repeated Doses, Double-blind, Placebo Controlled Study
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 23 Apr 2021
Price :
$35
*
At a glance
- Drugs REC 0438 (Primary)
- Indications Overactive bladder
- Focus Adverse reactions
- Sponsors Recordati
- 08 Nov 2019 Status changed from recruiting to completed.
- 07 Jun 2019 This trial has been completed in Czech Republic , according to European Clinical Trials Database.
- 02 Feb 2018 New trial record